Correction to “Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness-Death Modeling Study”

IF 2.9 2区医学 Q2 ONCOLOGY

Cancer Medicine Pub Date : 2024-11-18 DOI:10.1002/cam4.70417

引用次数: 0

Abstract

Hesami Z, Olfatifar M, Sadeghi A, Zali MR, Mohammadi-Yeganeh S, Habibi MA, Ghadir MR, Houri H. Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness-Death Modeling Study. Cancer Med. 2024 Oct;13(20):e70318. https://doi.org/10.1002/cam4.70318

The Ethical Code Acknowledgment is missing in the published paper. The Ethics Statement, “This project has been ethically approved by the Ethics Committee at Qom University of Medical Sciences, Qom, Iran (No. IR.MUQ.REC.1402.186).” should be placed after the Acknowledgment section.

We apologize for this error.

查看原文本刊更多论文

至 2040 年全球胰腺癌发病率趋势：疾病-死亡模型研究 "的更正。

Hesami Z、Olfatifar M、Sadeghi A、Zali MR、Mohammadi-Yeganeh S、Habibi MA、Ghadir MR、Houri H.《2040 年全球胰腺癌患病率趋势：疾病-死亡模型研究》。Cancer Med.2024 Oct;13(20):e70318. https://doi.org/10.1002/cam4.70318The 发表的论文中缺少伦理规范致谢。伦理声明 "本项目已获得伊朗库姆市库姆医科大学伦理委员会的伦理批准（编号：IR.MUQ.REC.1402.186）"应放在致谢部分之后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Medicine ONCOLOGY-

CiteScore

5.50

自引率

2.50%

发文量

907

审稿时长

19 weeks

期刊介绍： Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.